Karista operates two specialized funds—a HealthTech fund focused on AI- and data-driven pharma/medtech and a SpaceTech/Defence/Cyber fund explicitly sponsored by CNES (the French space agency)—rather than pursuing traditional biotech or generic deeptech investments. The firm acts as the first institutional investor in highly technical markets and then actively engineers syndicates with cross-border co-investors to position companies as category leaders, while maintaining a 20+ year European track record spanning now-listed successes like Sequans Communications and Nanobiotix.